Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Other Working Capital Changes (2020 - 2025)

Historic Other Working Capital Changes for LifeStance Health (LFST) over the last 6 years, with Q3 2025 value amounting to -$12.3 million.

  • LifeStance Health's Other Working Capital Changes fell 92.49% to -$12.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$48.3 million, marking a year-over-year increase of 6111.62%. This contributed to the annual value of -$46.7 million for FY2024, which is 2444.89% down from last year.
  • According to the latest figures from Q3 2025, LifeStance Health's Other Working Capital Changes is -$12.3 million, which was down 92.49% from -$11.6 million recorded in Q2 2025.
  • LifeStance Health's 5-year Other Working Capital Changes high stood at $69.2 million for Q3 2023, and its period low was -$89.9 million during Q4 2023.
  • Moreover, its 5-year median value for Other Working Capital Changes was -$9.6 million (2024), whereas its average is -$7.6 million.
  • As far as peak fluctuations go, LifeStance Health's Other Working Capital Changes tumbled by 40384.92% in 2022, and later soared by 1494826.09% in 2023.
  • Quarter analysis of 5 years shows LifeStance Health's Other Working Capital Changes stood at -$3.8 million in 2021, then crashed by 403.85% to -$19.0 million in 2022, then crashed by 373.43% to -$89.9 million in 2023, then soared by 86.15% to -$12.4 million in 2024, then grew by 0.94% to -$12.3 million in 2025.
  • Its Other Working Capital Changes stands at -$12.3 million for Q3 2025, versus -$11.6 million for Q2 2025 and -$11.9 million for Q1 2025.